ARPA-H Smart Band-Aid to Measure Chronic Pain in Women
Northwestern University · with Tufts University, Advanced Research Projects Agency for Health (ARPA-H) · NCT06994988
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 115
- US sites recruiting
- 1
- Study start
- July 6, 2026
- Record last updated
- September 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to test whether a minimally invasive microneedle patch, called the A-Band (Smart Band-aid), worn on the arm (monitoring key biomarkers in interstitial fluid) and a commercial smartwatch can accurately correlate with self-reported pain in women with chronic pain. A secondary purpose of the study is to identify demographic and clinical variables impacting pain measurement.
The main questions that this study aims to answer are:
- What is the correlation between AI-adjusted pain scores, based on biomarkers and validated tools, and self-reported pain scores?
- What influence do demographic and clinical information have in the correlation of these pain scores?
Researchers will compare data from these tools with self-reported pain scores in women with chronic pain and healthy women.
Participants will
- Be a part of the study for approximately 8 days
- Attend 2-3 in-person visits at the applicable clinical center over approximately one week
- Wear a Smart Band-Aid (A-Band) at least twice per day for a week, with each application lasting up to 90 minutes
- Complete questionnaires regarding medical history, pain information, mental health, sleep, and demographic data
- Record daily pain scores
- Wear a smartwatch for one week which will collect biophysical data (heart rate, skin response, etc.)
- Collect daily saliva samples
- Have blood drawn by medical staff at 2 in-person visits
Being studied: A-Band (Smart Band-Aid); Empatica Smartwatch; Questionnaires: Hospital Anxiety & Depression Scale, Central Sensitization Inventory, Pain Catastrophizing Scale, Somatic Symptom Scale-8, Pain Self-Efficacy Questionnaire-10, Athens Insomnia Scale
Conditions: Chronic Pain
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
For chronic pain group
- Female, 18 years or older.
- Diagnosis of chronic pain condition (e.g., fibromyalgia, chronic lower back pain) as determined by the Principal Investigator.
- Ability to provide informed consent.
For healthy controls
- Female, 18 years or older.
- No history of chronic pain.
- No significant or poorly controlled medical conditions as determined by the Principal Investigator and exclusion criteria.
- No significant active, poorly controlled psychological conditions as determined by the Principal Investigator and exclusion criteria.
- Ability to provide informed consent.
Exclusion Criteria (both groups):
- Pregnant or breastfeeding women.
- Substance abuse or psychiatric disorders that interfere with study participation.
- Major medical conditions (such as severe cardiovascular, neurological, cancer or autoimmune diseases) or psychological conditions (e.g., active, poorly-controlled depression, anxiety disorder, PTSD, substance use disorder) that interfere with study participation.
- Possibility of secondary financial gain from participation
- Interventional pain treatment(s) within 6 weeks of baseline (injection, epidural, etc.)
- Current opioid usage or usage within 2 weeks of baseline
Recruiting US locations
Northwestern University Feinberg School of Medicine
Chicago, IL 60611
Site contact: Jordan Wood, BS · 312-695-0915 · jordan.wood1@northwestern.edu
Study contacts (from the official record)
- Jordan Wood, BS · 312-695-0915 · jordan.wood1@northwestern.edu
Similar studies in Illinois
All pain studies in Illinois →- RecruitingPhase 3
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Adneuris Therapeutics, Inc.
- Location
- O'Fallon, IL + 14 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
Kuros Biosurgery AG
- Location
- Chicago, IL + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Chicago, IL + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
DiscGenics, Inc.
- Location
- Chicago, IL + 29 other US sites
- Eligibility basics
- Ages 18–75